LENVATINIB
Clinical trials for LENVATINIB explained in plain language.
Never miss a new study
Get alerted when new LENVATINIB trials appear
Sign up with your email to follow new studies for LENVATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to stop bile duct cancer from coming back
Disease control OngoingThis study tests whether giving a combination of immunotherapy (Toripalimab), a targeted drug (Lenvatinib), and chemotherapy (GEMOX) before surgery can improve outcomes for people with a high-risk type of bile duct cancer. About 178 participants will be randomly assigned to recei…
Matched conditions: LENVATINIB
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
2500 liver cancer patients tracked to see if new drugs beat old standard
Knowledge-focused OngoingThis study looks back at the medical records of 2500 liver cancer patients treated at a major hospital in Taiwan between 2019 and 2024. Researchers want to see how well newer drugs like Pembrolizumab, Atezolizumab, and Lenvatinib work compared to the older drug sorafenib. They wi…
Matched conditions: LENVATINIB
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 10:49 UTC
-
Can scans decide who needs surgery after liver tumor shrinks?
Knowledge-focused OngoingThis study looks back at 500 people with liver cancer that was too large to remove at first. After a mix of treatments (TACE, lenvatinib, and an immunotherapy drug), their tumors shrank enough to consider surgery. Researchers will use scans and medical records to see if certain p…
Matched conditions: LENVATINIB
Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Knowledge-focused
Last updated May 26, 2026 10:32 UTC